Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy study

S. E. Kjeldsen; P. Dzongowski; N. Li; L. Wang; A. Radlmaier

doi:10.1111/jcpt.12451

Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy study

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.12451 ◽

2016 ◽

Vol 41 (6) ◽

pp. 695-702

Author(s):

S. E. Kjeldsen ◽

P. Dzongowski ◽

N. Li ◽

L. Wang ◽

A. Radlmaier

Keyword(s):

Candesartan Cilexetil ◽

Fixed Dose ◽

Efficacy Study ◽

Therapeutic System ◽

Open Label ◽

Safety And Efficacy ◽

Gastrointestinal Therapeutic System ◽

Dose Combination ◽

Nifedipine Gastrointestinal Therapeutic System

Download Full-text

Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication

Expert Opinion on Pharmacotherapy ◽

10.1517/14656560802707937 ◽

2009 ◽

Vol 10 (3) ◽

pp. 345-352 ◽

Cited By ~ 4

Author(s):

Steen Neldam ◽

Colin Edwards

Keyword(s):

Antihypertensive Medication ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Open Label ◽

Safety And Efficacy ◽

Dose Combination

Download Full-text

Safety and efficacy of fixed‐dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam in adolescent patients (aged 12 to <17 years) with plaque psoriasis: results of a phase II , open‐label trial

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.16233 ◽

2020 ◽

Vol 34 (9) ◽

pp. 2026-2034 ◽

Cited By ~ 2

Author(s):

M. Seyger ◽

W. Abramovits ◽

M. Liljedahl ◽

M.N. Hoejen ◽

J. Teng

Keyword(s):

Phase Ii ◽

Plaque Psoriasis ◽

Betamethasone Dipropionate ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Open Label ◽

Safety And Efficacy ◽

Adolescent Patients ◽

Dose Combination ◽

Open Label Trial

Download Full-text

Percutaneous Endoscopic Gastrojejunostomy as a Novel Method of Drug Delivery for the Treatment of Parkinsonʼs Disease: Interim Results of an Open-Label, Long-Term Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel

The American Journal of Gastroenterology ◽

10.14309/00000434-201110002-01425 ◽

2011 ◽

Vol 106 ◽

pp. S545

Author(s):

Arvydas Vanagunas ◽

George Smallfield ◽

Nathan Schmulewitz ◽

Peter Crookes ◽

Janet Benesh ◽

...

Keyword(s):

Drug Delivery ◽

Efficacy Study ◽

Open Label ◽

Safety And Efficacy ◽

Novel Method

Download Full-text

SAFETY AND EFFICACY OF ONCE-DAILY CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE VERSUS NIFEDIPINE GASTROINTESTINAL THERAPEUTIC SYSTEM IN BLACK PATIENTS WITH MILD TO MODERATE HYPERTENSION

American Journal of Therapeutics ◽

10.1097/00045391-199612000-00005 ◽

1996 ◽

Vol 3 (12) ◽

pp. 811-817 ◽

Cited By ~ 1

Author(s):

M. R. Weir ◽

D. Sugimoto ◽

J. Gray ◽

H. Black ◽

E. Saunders ◽

...

Keyword(s):

Moderate Hypertension ◽

Therapeutic System ◽

Once Daily ◽

Safety And Efficacy ◽

Gastrointestinal Therapeutic System ◽

Black Patients ◽

Nifedipine Gastrointestinal Therapeutic System

Download Full-text

Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(17)30163-2 ◽

2017 ◽

Vol 2 (11) ◽

pp. 814-823 ◽

Cited By ~ 9

Author(s):

Eric Lawitz ◽

Maria Buti ◽

John M Vierling ◽

Piero L Almasio ◽

Savino Bruno ◽

...

Keyword(s):

Chronic Hepatitis ◽

Fixed Dose ◽

Combination Regimen ◽

Phase 2 ◽

Genotype 1 ◽

Virus Genotype ◽

Open Label ◽

Safety And Efficacy ◽

Chronic Hepatitis C Virus ◽

Dose Combination

Download Full-text

A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase

Pain Medicine ◽

10.1093/pm/pnw212 ◽

2016 ◽

pp. pnw212

Author(s):

Donald C. Manning ◽

Joseph Gimbel ◽

Robert Wertz ◽

Richard Rauck ◽

Alyse Cooper ◽

...

Keyword(s):

Phase Ii ◽

Radicular Pain ◽

Efficacy Study ◽

Open Label ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Open Label Extension ◽

Lumbar Radicular Pain

Download Full-text

Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study

Malaria Journal ◽

10.1186/s12936-016-1084-1 ◽

2016 ◽

Vol 15 (1) ◽

Cited By ~ 10

Author(s):

Neena Valecha ◽

Deepali Savargaonkar ◽

Bina Srivastava ◽

B. H. Krishnamoorthy Rao ◽

Santanu K. Tripathi ◽

...

Keyword(s):

Plasmodium Vivax ◽

Vivax Malaria ◽

Phase Iii ◽

Fixed Dose ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Plasmodium Vivax Malaria ◽

Dose Combination

Download Full-text

Long-Term Safety and Efficacy of a Unique Fixed-Dose Combination Gel of Adapalene 0.1% and Benzoyl Peroxide 2.5% for the Treatment of Acne Vulgaris

Journal of the Dermatology Nurses’ Association ◽

10.1097/01.jdn.0000350427.23616.3b ◽

2009 ◽

Vol 1 (2) ◽

pp. 146 ◽

Cited By ~ 1

Author(s):

David M. Pariser ◽

Patricia Westmoreland ◽

Amy Morris ◽

Michael H. Gold ◽

Yin Liu ◽

...

Keyword(s):

Benzoyl Peroxide ◽

Acne Vulgaris ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Safety And Efficacy ◽

Dose Combination

Download Full-text

Effect of zoledronic acid therapy on postmenopausal osteoporosis between the Uighur and Han population in Xinjiang: An open-label, long-term safety and efficacy study

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.12647 ◽

2017 ◽

Vol 43 (3) ◽

pp. 336-341

Author(s):

W. Xu ◽

C. Xiang ◽

H. Wang ◽

H. Yuan ◽

X. Zhao ◽

...

Keyword(s):

Zoledronic Acid ◽

Postmenopausal Osteoporosis ◽

Efficacy Study ◽

Open Label ◽

Acid Therapy ◽

Safety And Efficacy ◽

Han Population

Download Full-text

Long-term patient-reported outcomes from an open-label safety and efficacy study of bosutinib in Philadelphia chromosome-positive chronic myeloid leukemia patients resistant or intolerant to prior therapy

Cancer ◽

10.1002/cncr.31082 ◽

2017 ◽

Vol 124 (3) ◽

pp. 587-595 ◽

Cited By ~ 9

Author(s):

Hagop M. Kantarjian ◽

Carla M. Mamolo ◽

Carlo Gambacorti-Passerini ◽

Jorge E. Cortes ◽

Tim H. Brümmendorf ◽

...

Keyword(s):

Chronic Myeloid Leukemia ◽

Myeloid Leukemia ◽

Patient Reported Outcomes ◽

Philadelphia Chromosome ◽

Efficacy Study ◽

Open Label ◽

Safety And Efficacy ◽

Prior Therapy ◽

Patient Reported

Download Full-text